The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Jamrock if you are referring to Lloyds pharmacies they are now defunct, they are now Alliance healthcare. Looking in my local store they stock about 50% of what Lloyds did and majority of people only go there for prescriptions, so as far as stocking Mhc's products I think its a big no!
John Cornford, "Master Investor".....
John is semi-retired after 40 years in City research of one sort or another covering most sectors, and an earlier career in the MoD and management consulting. As well as institutional research he has also long taken an interest in research for private investors, editing the long established and top performing Investors Stockmarket Weekly in the ‘90s, and later Small Cap Shares. In the noughties he worked for seven years with Hardman and published his own research for institutions via his FourSquare Research. He believes it is scandalous that the FCA’s misplaced rules have denied quality research to private investors - leaving them at the mercy of bucket shops and tipsters.
Gold’s recent almost doubling from its 6p lows is, I think, an enormous bear trap – set off by the spike in gold, in turn stimulated by the Palestine war and interest rate speculation and which might not continue, and by chartist mumbo-jumbo. Either way nothing has changed (yet) to make Greatland a less risky investment at current levels. There are still big traps ahead. The updated Havieron resource statement due soon won’t, I think, boost the shares as much as the hopefuls think. That is because most informed opinion doesn’t believe the mineable gold there will double and, more important but not appreciated by the hopefuls, is that even a larger resource, if it won’t be mined for a long time ahead as will be the case for what Havieron has been drilling, won’t be accorded nearly as much value as nearer term production. The reason is obvious. Who knows what costs and commodity prices will be that far ahead ?. And whatever is definitely monetised in the far future will have a heavily discounted present value today.
The second reason of course is the continuing uncertainty what Havieron’s new 70% owner, Newmont, will do with it. Opinion seems to be swinging towards its retention, rather than a ‘sale’ back to Greatland Gold. If so, Newmont’s plans for it won’t necessarily be in GGP’s favour, especially in regard to the timing of the necessary additional investment that an expanded mining plan and much higher costs looks certain to call for and which GGP at the moment can ill afford. Whatever outcome, it isn’t clear that GGP shareholders won’t avoid substantial dilution, at least in the medium term.
SRT Marine Systems (LON:SRT) – The Buyers Are Returning
Yesterday I noticed that in a much busier dealing counter the shares of this group topped at 46.55p before closing 2.75p better at 45p.
SRT develops, manufactures and supplies maritime tracking technology and turn-key system solutions to marine stakeholders across the globe with a particular expertise in AIS.
The company’s products and solutions are used by individual vessel owners, port authorities, maritime infrastructure owners, coast guards and national security agencies to enhance their maritime domain awareness.
Applications include the tracking of commercial and leisure vessels; sustainable fishery; illegal fishing detection; law enforcement; anti-collision; search and rescue; waterway management, port and coast security; pollution management; and environmental management.
Analysts Kimberley Carstens and Michael Hill at Cavendish Capital rate highly the group’s shares, pitching for 100p a share in due course.
They see the £0.3m loss of last year turning into a massive £7.2m profit in the current year to end March 2024, worth 3.8p in earnings per share.
For the coming year they go for £11.8m profits, worth 6.2p in earnings.
Regular readers will know just how keen I am on these shares, I am convinced that its potential will shine through glaringly in 2024 (mark my words).
Check out my Profile piece on the company on the 13th September https://masterinvestor.co.uk/latest/srt-marine-systems-these-shares-could-double/
The value here hadn't been exposed yet but companies realise what Optimal does then we can expect more contracts. Many companies are under pressure with finances at the moment which is why the sp is where it is because every ceo has a duty to select the best possible deal. Going into '24 purse strings will open and more contracts will come....especially from the USA.
Cheers, Alamo🎄🎅
XxProInvestorxx....in reply to your comments about me. What I heard before was mainly about Arexvy, dest was mentioned with ref to XF 73, unsubstantiated. Again rumours about XF73, I took it with a pinch of salt but as I said it's only what I heard. You learn to listen closely depending on where and who you're listening to. I believe an update will happen before Xmas, CT doesn't hang about.
I work 2 days a week in Finsbury close to the LSE, I hear stuff all the time, some substantiated, a lot unsubstantiated, what I hear coming out is GSK are circling, the same as I heard a month ago. What happens here on in is anybody guess but no smoke without fire.
......just studied the charts and it's a green inverted hammer......
"A green inverted hammer candlestick often occurs at the end of a downtrend which signifies a possible bullish turn in the market. The long upper wick suggests that buyers are now pushing the prices of the commodity back up and the market may see a bullish price reversal"